EP2345402A1 - Cosmetic cleansing composition comprising a derivative of jasmonic acid and a surface active agent - Google Patents

Abstract

Cleaning composition (I) comprises at least one anionic or amphoteric foaming surfactant and at least one compound derived from jasmonic acid comprising cyclopentanol compounds (A) and their optical isomers, and corresponding salts. Cleaning composition (I) comprises at least one anionic or amphoteric foaming surfactant and at least one compound derived from jasmonic acid comprising cyclopentanol compounds of formula (A) and their optical isomers, and corresponding salts. R1 : COOR 3; R 3 : 1-4C alkyl (optionally substituted by one or more OH group) or H; and R 2 : optionally saturated, linear 1-18C hydrocarbyl or branched or cyclic 3-18C hydrocarbyl. An independent claim is included for process of cleaning a keratin material comprising applying (I) to the keratin material; and rinsing the composition. [Image].

Description

The invention relates to a cosmetic cleaning composition containing, in an aqueous medium, a derivative of jasmonic acid and an anionic or amphoteric foaming surfactant, and to its uses for cleaning and / or removing make-up from keratin materials such as skin, mucous membranes, lips, and / or keratinous fibers such as eyelashes or hair.

The cleaning of the skin is very important for the care of the face. It must be as efficient as possible because fatty residues such as excess sebum, the remains of cosmetics used daily and makeup products accumulate in skin folds and can clog the pores of the skin and lead to appearance of buttons. One way to clean the skin properly is to use foaming cleansers.

One of the major difficulties in the formulation of foaming products is to develop products having a very good foaming power, the foam performance being generally connected by the consumers to an effective cleaning. For the formulation of a product of such quality, it is necessary to use foaming surfactants to ensure a fast, abundant, dense foam (which does not run on the face), easy to spread and which will allow a good rinsing ,

The Applicant has surprisingly discovered that the use of a particular jasmonic acid derivative in combination with an anionic or amphoteric foaming surfactant makes it possible to improve the qualities of the foam of the cleaning compositions.

dans laquelle :

• R1 représente un radical COOR3, R3 désignant un atome d'hydrogène ou un radical alkyle en C1-C4, éventuellement substitué par un ou plusieurs groupes hydroxyle ;
• R2 représente un radical hydrocarboné, saturé ou insaturé, linéaire ayant de 1 à 18 atomes de carbones, ou ramifié ou cyclique ayant de 3 à 18 atomes de carbone ;

ainsi que leurs isomères optiques, et sels correspondants.Thus, the subject of the invention is a cosmetic cleaning composition containing (1) at least one anionic or amphoteric foaming surfactant and (2) at least one compound derived from jasmonic acid chosen from those corresponding to the following formula (I) :

in which :

• R1 represents a radical COOR3, R3 denoting a hydrogen atom or a C1-C4 alkyl radical, optionally substituted by one or more hydroxyl groups;
• R2 represents a hydrocarbon radical, saturated or unsaturated, linear having 1 to 18 carbon atoms, or branched or cyclic having 3 to 18 carbon atoms;

as well as their optical isomers, and corresponding salts.

The composition of the invention has a good foaming power, including a dense and abundant foam, while being well rinsable.

The composition of the invention being a cosmetic composition, it contains a physiologically acceptable medium. Here is meant by "physiologically acceptable medium", a medium compatible with keratin materials. It is preferably a cosmetically acceptable medium, that is to say which, in addition, has a pleasant color, odor and feel and that does not generate unacceptable discomfort (tingling, tightness, redness ), likely to divert the consumer from using this composition.

The cleaning composition of the invention is a foaming composition which is rinsed after application to the skin.

Derived from jasmonic acid

dans laquelle :
R1 représente un radical COOR3, R3 désignant un atome d'hydrogène ou un radical alkyle en C1-C4 , éventuellement substitué par un ou plusieurs groupes hydroxyle ;
R2 représente un radical hydrocarboné, saturé ou insaturé, linéaire ayant de 1 à 18 atomes de carbones, ou ramifié ou cyclique ayant de 3 à 18 atomes de carbone ;
ainsi que leurs isomères optiques, et sels correspondants.The compound derived from jasmonic acid is a compound chosen from those corresponding to the following formula (I):

in which :
R1 represents a radical COOR3, R3 denoting a hydrogen atom or a C1-C4 alkyl radical, optionally substituted by one or more hydroxyl groups;
R2 represents a hydrocarbon radical, saturated or unsaturated, linear having 1 to 18 carbon atoms, or branched or cyclic having 3 to 18 carbon atoms;
as well as their optical isomers, and corresponding salts.

Preferably, R 1 denotes a radical chosen from -COOH, -COOMe, -COO-CH 2 -CH 3, -COO-CH 2 -CH (OH) -CH 2 OH, -COOCH 2 -CH 2 -CH 2 OH, -COOCH 2 -CH (OH) -CH 3 . Preferentially, R 1 denotes a -COOH radical.

Preferably, R2 denotes a hydrocarbon radical, linear, saturated or unsaturated, and preferably having from 2 to 7 carbon atoms. In particular, R ₂ may be a pentyl, pentenyl, hexyl or heptyl radical.

According to one embodiment, the compound of formula (I) is chosen from 3-hydroxy-2 - [(2Z) -2-pentenyl] -cyclopentane acetic acid or 3-hydroxy-2-pentylcyclopentane acetic acid, and preferably is 3-hydroxy-2-pentylcyclopentane acetic acid.

The salts of the compounds that may be used according to the invention are in particular chosen from alkali metal salts, for example sodium and potassium; alkaline earth metal salts, for example calcium, magnesium, strontium, metal salts, for example zinc, aluminum, manganese, copper; ammonium salts of formula NH ₄ ⁺ ; quaternary ammonium salts; organic amine salts, such as, for example, the salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2-hydroxyethylamine, bis (2-hydroxyethyl) amine, tri- (2- hydroxyethyl) amine; lysine salts, arginine. Salts chosen from sodium, potassium, calcium, magnesium, strontium, copper, manganese and zinc are preferably used.

The jasmonic acid derivative compound of formula (I) may be present in an amount of from 0.1 to 15% by weight, preferably from 0.2 to 10% by weight and more preferably from 0.5 to 5% by weight. weight relative to the total weight of the composition.

Anionic and amphoteric surfactants

The anionic and amphoteric (or zwitterionic) surfactants present in the composition according to the invention are preferably foaming surfactants capable of cleaning the skin.

Foaming surfactants are detergents and differ from emulsifiers by the value of their HLB (Hydrophilic Lipophilic Balance), the HLB being the ratio between the hydrophilic part and the lipophilic part in the molecule. The term HLB is well known to those skilled in the art and is described for example in " The HLB system. A Time-saving Guide to Emulsifying Selection "(published by ICI Americas Inc., 1984) ). For emulsifiers, the HLB generally ranges from 3 to 8 for the preparation of W / O emulsions and from 8 to 18 for the preparation of O / W emulsions, whereas the foaming surfactants generally have an HLB greater than 20.

The anionic and / or amphoteric foaming surfactants may be present in the composition in an amount (of active material) ranging, for example, from 0.1 to 40% by weight, preferably from 0.5 to 30% by weight, more preferably from 1 to 40% by weight. at 25% and more preferably from 3 to 20% by weight relative to the total weight of the composition.

Anionic surfactants

1. a) Les dérivés anioniques de protéines d'origine végétale sont des hydrolysats de protéine à groupement hydrophobe, ledit groupement hydrophobe pouvant être naturellement présent dans la protéine ou être ajouté par réaction de la protéine et/ou de l'hydrolysat de protéine avec un composé hydrophobe. Les protéines sont d'origine végétale ou dérivées de soie, et le groupement hydrophobe peut être notamment une chaîne grasse, par exemple une chaîne alkyle comportant de 10 à 22 atomes de carbone. Comme dérivés anioniques de protéines d'origine végétale, on peut plus particulièrement citer les hydrolysats de protéines de pomme, de blé, de soja, d'avoine, comportant une chaîne alkyle ayant de 10 à 22 atomes de carbone et leurs sels. La chaîne alkyle peut être notamment une chaîne lauryle et le sel peut être un sel de sodium, de potassium et/ou d'ammonium.
   Ainsi, comme hydrolysats de protéine à groupement hydrophobe, on peut citer par exemple les sels des hydrolysats de protéine de soie modifiée par l'acide laurique, tels que le produit commercialisé sous la dénomination KAWA SILK par la société Kawaken ; les sels des hydrolysats de protéine de blé modifiée par l'acide laurique, tels que le sel de potassium commercialisé sous la dénomination Aminofoam W OR par la société Croda (nom CTFA : Potassium lauroyl wheat aminoacids) et le sel de sodium commercialisé sous la dénomination PROTEOL LW 30 par la société Seppic (nom CTFA : sodium lauroyl wheat aminoacids) ; les sels des hydrolysats de protéine d'avoine comportant une chaîne alkyle ayant de 10 à 22 atomes de carbone, et plus spécialement les sels des hydrolysats de protéine d'avoine modifiée par l'acide laurique, tels que le sel de sodium commercialisé sous la dénomination PROTEOL OAT (soltion aqueuse à 30%) par la société Seppic (nom CTFA : Sodium lauroyl oat aminoacids) ; les sels des hydrolysats de protéine de pomme, comportant une chaîne alkyle ayant de 10 à 22 atomes de carbone, tels que le sel de sodium commercialisé sous la dénomination PROTEOL APL (solution hydroglycolique à 30%) par la société Seppic (nom CTFA : Sodium Cocoyl Apple amino acids). On peut citer aussi le mélange de lauroyl-aminoacides (aspartique, glutamique, glycine, alanine) neutralisé au N-methylglycinate de sodium, commercialisé sous la dénomination PROTEOL SAV 50 S par la société Seppic (nom CTFA : Sodium Cocoyl amino acids).
2. b) Comme phosphates et alkylphosphates, on peut citer par exemple les monoalkylphosphates et les dialkyl phosphates, tels que le mono-phosphate de lauryle commercialisé sous la dénomination MAP 20® par la société Kao Chemicals, le sel de potassium de l'acide dodécyl-phosphorique, mélange de mono- et di-ester (diester majoritaire) commercialisé sous la dénomination CRAFOL AP-31® par la société Cognis, le mélange de monoester et de di-ester d'acide octylphosphorique, commercialisé sous la dénomination CRAFOL AP-20® par la société Cognis, le mélange de monoester et de diester d'acide phophorique de 2-butyloctanol éthoxylé (7 moles d'OE), commercialisé sous la dénomination ISOFOL 12 7 EO-PHOSPHATE ESTER® par la société Condea, le sel de potassium ou de triéthanolamine de monoalkyl (C12-C13) phosphate commercialisé sous les références ARLATONE MAP 230K-40® et ARLATONE MAP 230T-60® par la société Uniqema, le lauryl phosphate de potassium commercialisé sous la dénomination DERMALCARE MAP XC-99/09® par la société Rhodia Chimie, et le cétylphosphate de potassium commercialisé sous la dénomination ARLATONE MAP 160K par la société Uniqema.
3. c) Comme carboxylates, on peut citer :
   • ● Les amido éthercarboxylates (AEC), comme le Lauryl amido ether carboxylate de sodium (3 OE), commercialisé sous la dénomination AKYPO FOAM 30® par la société Kao Chemicals.
   • ● les sels d'acides carboxyliques polyoxyéthylénés, comme le Lauryl ether carboxylate de sodium (C_12-14-16 65/25/10) oxyéthyléné (6 OE) commercialisé sous la dénomination AKYPO SOFT 45 NV® par la société Kao Chemicals, les acides gras d'origine huile d'olive polyoxyéthylénés et carboxyméthylés commercialisés sous la dénomination OLIVEM 400® par la société BIOLOGIA E TECNOLOGIA, le tri-decyl ether carboxylate de sodium oxyéthyléné (6 OE) commercialisé sous la dénomination NIKKOL ECTD-6NEX ® par la société Nikkol.
   • ● les sels d'acides gras (savons) ayant une chaîne alkyl en C6 à C22, neutralisés par une base organique ou minérale telle que la potasse, la soude, la triéthanolamine,la N-methyl glucamine, la lysine et l'arginine.
4. d) Comme dérivés des aminoacides, on peut citer notamment les sels alcalins d'aminoacides, tels que :
   • ● les sarcosinates, comme le Lauroyl sarcosinate de sodium commercialisé sous la dénomination SARKOSYL NL 97® par la société Ciba ou commercialisé sous la dénomination ORAMIX L 30® par la société Seppic, le myristoyl sarcosinate de sodium commercialisé sous la dénomination NIKKOL SARCOSINATE MN® par la société Nikkol, le palmitoyl sarcosinate de sodium commercialisé sous la dénomination NIKKOL SARCOSINATE PN ® par la société Nikkol.
   • ● les alaninates, comme le N-lauroyl-N methyl amidopropionate de sodium commercialisé sous la dénomination SODIUM NIKKOL ALANINATE LN 30® par la société Nikkol, ou commercialisé sous la dénomination ALANONE ALE® par la société Kawaken, le N-lauroyl N-methyl alanine triéthanolamine commercialisé sous la dénomination ALANONE ALTA ® par la société Kawaken.
   • ● Les glutamates, comme le mono-cocoyl glutamate de triéthanolamine commercialisé sous la dénomination ACYLGLUTAMATE CT-12® par la société Ajinomoto, le lauroylglutamate de triéthanolamine commercialisé sous la dénomination ACYLGLUTAMATE LT-12® par la société Ajinomoto.
   • ● les aspartates, comme le mélange de N-lauroyl aspartate de triethanolamine /N-myristoyl aspartate de triethanolamine commercialisé sous la dénomination ASPARACK® par la société Mitsubishi.
   • ● les dérivés de glycine (glycinates), comme le N-cocoyl glycinate de sodium commercialisé sous les dénominations AMILITE GCS-12® et AMILITE GCK 12 par la société Ajinomoto.
   • ● Les citrates tels que le mono-ester citrique d'alcools de coco oxyéthylénés (9 moles), commercialisé sous la dénomination WITCONOL EC 1129 par la société Goldschmidt.
   • ● les galacturonates tels que le dodeécyl d-galactoside uronate de sodium commercialisé par la société Soliance.
5. e) Comme sulfosuccinates, on peut citer par exemple le mono-sulfosuccinate d'alcool laurylique (C12/C14 70/30) oxyéthyléné (3 OE) commercialisé sous les dénominations SETACIN 103 SPECIAL®, REWOPOL SB-FA 30 K 4® par la société Witco, le sel di-sodique d'un hemi-sulfosuccinate des alcools C12-C14, commercialisé sous la dénomination SETACIN F SPECIAL PASTE® par la société Zschimmer Schwarz, l'oléamidosulfosuccinate di-sodique oxyéthyléné (2 OE) commercialisé sous la dénomination STANDAPOL SH 135® par la société Cognis, le mono-sulfosuccinate d'amide laurique oxyéthyléné (5 OE) commercialisé sous la dénomination LEBON A-5000® par la société Sanyo, le sel di-sodique de mono-sulfosuccinate de lauryl citrate oxyéthyléné (10 OE) commercialisé sous la dénomination REWOPOL SB CS 50® par la société Witco, le mono-sulfosuccinate de mono-éthanolamide ricinoléique commercialisé sous la dénomination REWODERM S 1333® par la société Witco. On peut utiliser aussi les sulfosuccinates de polydimethylsiloxane tels que le disodium PEG-12 dimethicone sulfosuccinate commercialisé sous la dénomination MACKANATE-DC30 par la société Mac Intyre.
6. f) Comme alkyl sulfates, on peut citer par exemple le lauryl sulfate de triéthanolamine (nom CTFA : TEA-lauryl sulfate) tel que le produit commercialisé par la société Huntsman sous la dénomination EMPICOL TL40 FL ou celui commercialisé par la société Cognis sur la dénomination TEXAPON T42, produits qui sont à 40% en solution aqueuse. On peut aussi citer le lauryl sulfate d'ammonium (nom CFTA : Ammonium lauryl sulfate) tel que le produit commercialisé par la société Huntsman sous la dénomination EMPICOL AL 30FL qui est à 30% en solution aqueuse.
7. g) Comme alkyl éther sulfates, on peut citer par exemple le lauryl éther sulfate de sodium (nom CTFA : sodium laureth sulfate) comme celui commercialisé sous les dénominations TEXAPON N40 et TEXAPON AOS 225 UP par la société Cognis, le lauryl éther sulfate d'ammonium (nom CTFA : ammonium laureth sulfate) comme celui commercialisé sous la dénomination STANDAPOL EA-2 par la société Cognis.
8. h) Comme sulfonates, on peut citer par exemple les alpha-oléfines sulfonates comme l'alpha-oléfine sulfonate de sodium (C14-16) commercialisé sous la dénomination BIO-TERGE AS-40® par la société Stepan, commercialisé sous les dénominations WITCONATE AOS PROTEGE® et SULFRAMINE AOS PH 12® par la société Witco ou commercialisé sous la dénomination BIO-TERGE AS-40 CG® par la société Stepan, l'oléfine sulfonate de sodium secondaire commercialisé sous la dénomination HOSTAPUR SAS 30® par la société Clariant ; les alkyl aryl sulfonates linéaires comme le xylène sulfonate de sodium commercialisé sous les dénominations MANROSOL SXS30®, MANROSOL SXS40®, MANROSOL SXS93® par la société Manro.
9. i) Comme iséthionates, on peut citer les acyliséthionates comme le cocoyl-iséthionate de sodium, tel que le produit commercialisé sous la dénomination JORDAPON Cl P® par la société Jordan.
10. j) Comme taurates, on peut citer le sel de sodium de méthyltaurate d'huile de palmiste commercialisé sous la dénomination HOSTAPON CT PATE® par la société Clariant ; les N-acyl N-méthyltaurates comme le N-cocoyl N-methyltaurate de sodium commercialisé sous la dénomination HOSTAPON LT-SF® par la société Clariant ou commercialisé sous la dénomination NIKKOL CMT-30-T® par la société Nikkol, le palmitoyl methyltaurate de sodium commercialisé sous la dénomination NIKKOL PMT® par la société Nikkol.
11. k) Les dérivés anioniques d'alkyl-polyglucosides peuvent être notamment des citrates, tartrates, sulfosuccinates, carbonates et éthers de glycérol obtenus à partir des alkyl polyglucosides. On peut citer par exemple le sel de sodium d'ester tartrique de cocoylpolyglucoside (1,4), commercialisé sous la dénomination EUCAROL AGE-ET® par la société Cesalpinia, le sel di-sodique d'ester sulfosuccinique de cocoylpolyglucoside (1,4), commercialisé sous la dénomination ESSAI 512 MP® par la société Seppic, le sel de sodium d'ester citrique de cocoyl polyglucoside (1,4) commercialisé sous la dénomination EUCAROL AGE-EC® par la société Cesalpinia.
12. l) Les savons sont obtenus à partir d'un acide gras qui est partiellement ou totalement saponifié (neutralisé) par un agent basique. Ce sont des savons de métal alcalin ou alcalino-terreux ou de bases organiques. Comme acides gras, on peut utiliser les acides gras saturés, linéaires ou ramifiés, comportant de 8 à 30 atomes de carbone, et de préférence comportant de 8 à 22 atomes de carbone. Cet acide gras peut être en particulier choisi parmi l'acide palmitique, l'acide stéarique, l'acide myristique, l'acide laurique et leurs mélanges.
    Comme agents basiques, on peut utiliser par exemple les hydroxydes de métaux alcalins (hydroxyde de sodium et hydroxyde de potassium ou potasse), les hydroxydes de métaux alcalino-terreux (par exemple de magnésium), l'hydroxyde d'ammonium, ou encore les bases organiques comme la triéthanolamine, la N-méthylglucamine, la lysine et l'arginine.
    Les savons peuvent être notamment des sels alcalins d'acide gras, l'agent basique étant un hydroxyde de métal alcalin, et de préférence l'hydroxyde de potassium ou potasse (KOH).
    La quantité d'agent basique doit être suffisante pour que l'acide gras soit au moins partiellement neutralisé.

The anionic surfactants that can be added to the composition according to the invention can be chosen in particular from anionic derivatives of proteins of plant origin or silk proteins, phosphates and alkylphosphates, carboxylates, sulphosuccinates, amino acid derivatives, alkyl sulfates, alkyl ether sulfates, sulfonates, isethionates, taurates, alkyl sulfoacetates, polypeptides, alkyl polyglucoside anionic derivatives, soaps (fatty acid salts) and mixtures thereof.

1. a) The anionic derivatives of proteins of vegetable origin are hydrolysates of protein with a hydrophobic group, said hydrophobic group possibly being naturally present in the protein or being added by reaction of the protein and / or the protein hydrolyzate with a compound hydrophobic. The proteins are of plant origin or silk derivatives, and the hydrophobic group may be in particular a fatty chain, for example an alkyl chain comprising from 10 to 22 carbon atoms. As anionic derivatives of proteins of vegetable origin, mention may be made more particularly of the hydrolysates of apple, wheat, soy and oat proteins, comprising an alkyl chain having from 10 to 22 carbon atoms and their salts. The alkyl chain may in particular be a lauryl chain and the salt may be a salt of sodium, potassium and / or ammonium.
   Thus, as hydrolysates of protein with a hydrophobic group, there may be mentioned, for example, the salts of lauric acid-modified silk protein hydrolysates, such as the product marketed under the name KAWA Silk by the company Kawaken; salts of hydrolysates of wheat protein modified with lauric acid, such as the potassium salt marketed under the name Aminofoam W OR by the company Croda (CTFA name: Potassium lauroyl wheat aminoacids) and the sodium salt marketed under the name PROTEOL LW 30 by the company Seppic (CTFA name: sodium lauroyl wheat aminoacids); salts of oat protein hydrolysates having an alkyl chain having from 10 to 22 carbon atoms, and more particularly salts of lauric acid modified oat protein hydrolysates, such as the sodium salt marketed under PROTEOL OAT designation (30% aqueous solution) by the company Seppic (CTFA name: Sodium lauroyl oat aminoacids); salts of apple protein hydrolysates, comprising an alkyl chain having from 10 to 22 carbon atoms, such as the sodium salt sold under the name PROTEOL APL (30% hydrogen glycolic solution) by the company Seppic (CTFA name: Sodium Cocoyl Apple amino acids). Mention may also be made of the mixture of lauroyl amino acids (aspartic, glutamic, glycine, alanine) neutralized with sodium N-methylglycinate, sold under the name PROTEOL SAV 50 S by the company Seppic (CTFA name: Sodium Cocoyl amino acids).
2. b) Phosphates and alkylphosphates include, for example, monoalkyl phosphates and dialkyl phosphates, such as lauryl mono-phosphate sold under the name MAP 20® by the company Kao Chemicals, the potassium salt of dodecyl acid, phosphoric acid, mixture of mono- and di-ester (majority diester) marketed under the name CRAFOL AP-31® by Cognis, the mixture of monoester and octylphosphoric acid di-ester, sold under the name CRAFOL AP-20 ® by the company Cognis, the mixture of monoester and diester of ethoxylated 2-butyloctanol phophoric acid (7 moles of EO), sold under the name ISOFOL 12 7 EO-PHOSPHATE ESTER® by the company Condea, the salt of potassium or triethanolamine monoalkyl (C12-C13) phosphate sold under the references ARLATONE MAP 230K-40® and ARLATONE MAP 230T-60® by the company Uniqema, lauryl phosphate potassium marketed under the name DERMALCARE MAP XC-99 / 09® by the company Rhodia Chimie, and potassium cetyl phosphate marketed under the name ARLATONE MAP 160K by the company Uniqema.
3. c) As carboxylates, mention may be made of:
   • ● Amido ether carboxylates (AEC), such as sodium lauryl amido ether carboxylate (3 EO), sold under the name AKYPO FOAM 30® by the company Kao Chemicals.
   • The salts of polyoxyethylenated carboxylic acids, such as sodium lauryl ether carboxylate (C _12-14-16 65/25/10) oxyethylenated (6 EO) sold under the name AKYPO SOFT 45 NV® by the company Kao Chemicals, polyoxyethylenated and carboxymethylated olive oil fatty acids marketed under the name OLIVEM 400® by the company BIOLOGIA E TECNOLOGIA, the oxyethylenated (6 EO) tri-decyl ether carboxylate sold under the name NIKKOL ECTD-6NEX® by the company Nikkol company.
   • ● salts of fatty acids (soaps) having a C6 to C22 alkyl chain, neutralized with an organic or inorganic base such as potassium hydroxide, sodium hydroxide, triethanolamine, N-methylglucamine, lysine and arginine.
4. d) Amino acid derivatives which may be mentioned in particular are the alkaline salts of amino acids, such as:
   • Sarcosinates, such as sodium Lauroyl sarcosinate sold under the name SARKOSYL NL 97® by the company Ciba or marketed under the name ORAMIX L 30® by the company Seppic, sodium myristoyl sarcosinate sold under the name NIKKOL SARCOSINATE MN® by Nikkol, the sodium palmitoyl sarcosinate sold under the name NIKKOL SARCOSINATE PN ® by the company Nikkol.
   • Alaninates, such as sodium N-lauroyl-N-sodium amidopropionate sold under the name Sodium Nikkol Alkanate LN 30® by the company Nikkol, or sold under the name Alanone Ale® by the company Kawaken, N-lauroyl N-methyl; alanine triethanolamine sold under the name ALANONE ALTA® by the company Kawaken.
   • ● Glutamates, such as triethanolamine mono-cocoyl glutamate sold under the name ACYLGLUTAMATE CT-12® by Ajinomoto, triethanolamine lauroylglutamate marketed under the name ACYLGLUTAMATE LT-12® by the company Ajinomoto.
   • Aspartates, such as the mixture of N-lauroyl aspartate triethanolamine / N-myristoyl aspartate triethanolamine marketed under the name ASPARACK® by the company Mitsubishi.
   • Glycine derivatives (glycinates), such as sodium N-cocoyl glycinate marketed under the names AMILITE GCS-12® and AMILITE GCK 12 by the company Ajinomoto.
   • ● Citrates such as the citric monoester of oxyethylenated coconut alcohols (9 moles), sold under the name WITCONOL EC 1129 by the company Goldschmidt.
   • ● galacturonates such as sodium dodecyl d-galactoside uronate marketed by Soliance.
5. e) As sulfosuccinates, mention may be made, for example, of oxyethylenated (3 EO) lauryl alcohol (C12 / C14 70/30) monosulphysuccinate sold under the names SETACIN 103 SPECIAL® and REWOPOL SB-FA 30 K 4® by Witco company, the di-sodium salt of a hemi-sulfosuccinate of C12-C14 alcohols, marketed under the name SETACIN F SPECIAL PASTE® by the company Zschimmer Schwarz, the oxyethylenated (2 EO) di-sodium oleamide sulfosuccinate sold under the name STANDAPOL SH 135® by the company Cognis, the oxyethylenated (5 EO) lauric amide mono-sulfosuccinate sold under the name LEBON A-5000® by the company Sanyo, the di-sodium salt of oxyethylenated lauryl citrate monosulfinate ( 10 OE) sold under the name REWOPOL SB CS 50® by the company Witco, the ricinoleic mono-ethanolamide mono-sulfosuccinate sold under the name REWODERM S 1333® by the company Witco. It is also possible to use polydimethylsiloxane sulphosuccinates such as the disodium PEG-12 dimethicone sulphosuccinate marketed under the name MACKANATE-DC30 by Mac Intyre.
6. f) As alkyl sulphates, mention may be made, for example, of triethanolamine lauryl sulphate (CTFA name: TEA-lauryl sulphate) such as the product marketed by Huntsman under the name EMPICOL TL40 FL or that marketed by Cognis on the denomination TEXAPON T42, products that are 40% in aqueous solution. It is also possible to mention ammonium lauryl sulphate (CFTA name: Ammonium lauryl sulphate), such as the product marketed by Huntsman under the name EMPICOL AL 30FL which is 30% in aqueous solution.
7. g) As alkyl ether sulphates, mention may be made, for example, of sodium lauryl ether sulphate (CTFA name: sodium laureth sulfate), such as that marketed under the names TEXAPON N40 and TEXAPON AOS 225 UP by the company Cognis, lauryl ether sulphate. ammonium (CTFA name: ammonium laureth sulfate) such as that marketed under the name Standapol EA-2 by Cognis.
8. h) As sulphonates, mention may be made, for example, of alpha-olefin sulphonates, such as sodium alpha-olefin sulphonate (C14-16) sold under the name BIO-TERGE AS-40® by the company Stepan, marketed under the names WITCONATE AOS PROTEGE® and SULFRAMINE AOS PH 12® by the company Witco or sold under the name BIO-TERGE AS-40 CG® by Stepan, the secondary sodium olefin sulfonate sold under the name Hostapur SAS 30® by the company Clariant ; linear alkyl aryl sulphonates, such as sodium xylene sulphonate sold under the names MANROSOL SXS30®, MANROSOL SXS40® and MANROSOL SXS93® by the company Manro.
9. i) As isethionates, mention may be made of acylisethionates such as sodium cocoylisethionate, such as the product sold under the name JORDAPON Cl P® by the company Jordan.
10. j) As taurates, mention may be made of the sodium salt of palm kernel oil methyltaurate marketed under the name HOSTAPON CT PATE® by the company Clariant; N-acyl N-methyltaurates, such as the sodium N-cocoyl N-methyltaurate sold under the name HOSTAPON LT-SF® by the company Clariant or marketed under the trademark NIKKOL CMT-30-T® by Nikkol, palmitoyl methyltaurate sodium sold under the name NIKKOL PMT® by the company Nikkol.
11. k) The anionic derivatives of alkyl polyglucosides can be in particular citrates, tartrates, sulfosuccinates, carbonates and glycerol ethers obtained from the alkyl polyglucosides. Mention may be made, for example, of the sodium salt of cocoylpolyglucoside (1,4) tartaric ester, sold under the name EUCAROL AGE-ET® by the company Cesalpinia, the sodium salt of cocoylpolyglucoside sulfosuccinic ester (1,4). ), marketed under the name ESSAI 512 MP® by the company Seppic, the sodium salt of citric ester cocoyl polyglucoside (1,4) sold under the name EUCAROL AGE-EC® by the company Cesalpinia.
12. l) Soaps are obtained from a fatty acid that is partially or totally saponified (neutralized) with a basic agent. These are alkali or alkaline-earth metal soaps or organic bases. As fatty acids, it is possible to use saturated, linear or branched fatty acids containing from 8 to 30 carbon atoms, and preferably containing from 8 to 22 carbon atoms. This fatty acid may in particular be chosen from palmitic acid, stearic acid, myristic acid, lauric acid and mixtures thereof.
    As basic agents, it is possible to use, for example, alkali metal hydroxides (sodium hydroxide and potassium hydroxide or potassium hydroxide), alkaline earth metal hydroxides (for example magnesium), ammonium hydroxide, or even organic bases such as triethanolamine, N-methylglucamine, lysine and arginine.
    The soaps may be in particular alkali salts of fatty acid, the basic agent being an alkali metal hydroxide, and preferably potassium hydroxide or potassium hydroxide (KOH).
    The amount of basic agent must be sufficient for the fatty acid to be at least partially neutralized.

Preferably, the anionic surfactant is chosen from alkyl sulphates, alkyl ether sulphates such as sodium lauryl ether sulphate, isethionates and amino acid derivatives, in particular glycine derivatives (glycinates), such as N-cocoyl glycinate. sodium and mixtures thereof.

Amphoteric and zwitterionic foaming surfactants

The amphoteric and zwitterionic surfactants may be chosen for example from betaines, N-alkylamidobetaines and their derivatives, sultaines, alkyl polyaminocarboxylates, alkylamphoacetates and mixtures thereof.

As betaines, there may be mentioned in particular alkylbetaines such as cocobetaine such as the product sold under the name DEHYTON AB-30® by the company Cognis, laurylbetaine as the product sold under the name GENAGEN KB® by the company Clariant, laurylbetaine oxyethylenated (10 EO), such as the product sold under the name LAURYLETHER (10 OE) BETAINE® by the company Shin Nihon Rica, stearylbetaine oxyethylenated (10 EO), such as the product marketed under the name STEARYLETHER (10 EO) BETAINE® by the company Shin Nihon Rica company.

Among the N-alkylamidobetaines and their derivatives, mention may be made, for example, of cocamidopropyl betaine marketed under the name LEBON 2000 HG® by the company Sanyo, or marketed under the name EMPIGEN BB® by the company Albright & Wilson, lauramidopropyl betaine marketed under the name REWOTERIC AMB12P® by the company Witco.

As sultaines, mention may be made of hydroxylsultaines, such as cocamidopropyl hydroxysultaine such as the product sold under the name REWOTERIC AM CAS by the company Golschmidt-Degussa, or the product marketed under the name CROSULTAINE C-50® by the company Croda.

As alkyl polyaminocarboxylates (APAC), mention may be made of sodium cocoylpolyamino carboxylate, sold under the name AMPHOLAK 7 CX / C®, and AMPHOLAK 7 CX® by the company Akzo Nobel, the sodium stearyl-polyamidocarboxylate sold under the name AMPHOLAK. 7 TX / C by Akzo Nobel, sodium carboxymethylolpropylamine, marketed under the name AMPHOLAK XO7 / C® by the company Akzo Nobel.

As alkylamphoacetates, mention may be made, for example, of N-cocoyl-N-carboxymethoxyethyl-N-carboxymethyl-ethylenediamine N-di-sodium (CTFA name: disodium cocoamphodiacetate), such as the product marketed under the name MIRANOL C2M CONCENTRA NP® by the company Rhodia N-cocoyl-N-hydroxyethyl-N-carboxymethyl-ethylenediamine N-sodium (CTFA name: sodium cocamphoacetate), sodium cocoamphohydroxypropyl sulphonate sold under the name MIRANOL CSE by the company Rhodia.

Preferably, the amphoteric or zwitterionic surfactant is chosen from betaines, and in particular alkylbetaines, alkylamphoacetates, such as sodium cocamphoacetate, and mixtures thereof.

The composition according to the invention may contain, in addition to the anionic or amphoteric foaming surfactants, one or more additional foaming surfactants chosen from nonionic surfactants, cationic surfactants and mixtures thereof.

Nonionic foaming surfactant

The nonionic foaming surfactants of the composition of the invention may be chosen in particular from alkyl polyglucosides (APG), oxyalkylenated glycerol esters and oxyalkylenated sugar esters, and mixtures thereof. These are preferably APGs.

Preferred alkylpolyglucosides are those containing an alkyl group having 6 to 30 carbon atoms and preferably 8 to 16 carbon atoms, and containing a glucoside group preferably comprising 1.2 to 3 glucoside units. The alkylpolyglucosides may be chosen for example from decylglucoside (Alkyl-C9 / Cl-polyglucoside (1.4)) such as the product sold under the name Mydol 10® by the company Kao Chemicals or the product marketed under the name Plantacare 2000 UP® by the company Cognis company; caprylyl / capryl glucoside, such as the product marketed under the name Plantacare KE 3711® by the company Cognis; laurylglucoside, such as the product marketed under the name Plantacare 1200 UP® by Cognis; cocoglucoside, such as the product marketed under the name Plantacare 818 UP® by the company Cognis; caprylylglucoside, such as the product marketed under the name Plantacare 810 UP® by Cognis; and their mixtures.

The oxyalkylenated glycerol esters are in particular the polyoxyethylenated derivatives of glyceryl and fatty acid esters and their hydrogenated derivatives. These oxyalkylenated glycerol esters may be chosen, for example, from glyceryl esters of hydrogenated and oxyethylenated fatty acids such as PEG-200 hydrogenated glyceryl. palmate marketed under the name Rewoderm LI-S 80 by the company Goldschmidt; oxyethylenated glyceryl cocoates such as PEG-7 glyceryl cocoate sold under the name Tegosoft GC by the company Goldschmidt, and PEG-30 glyceryl cocoate sold under the name Rewoderm LI-63 by the company Goldschmidt; and their mixtures.

The oxyalkylenated sugar esters are in particular the polyethylene glycol ethers of the fatty acid and sugar esters. These oxyalkylenated sugar esters may be chosen for example from oxyethylenated glucose esters such as PEG-120 methyl glucose dioleate sold under the name Glucamate DOE 120 by the company Amerchol.

According to a preferred embodiment of the invention, the nonionic surfactant is an alkylpolyglucoside which may be chosen in particular from decylglucoside, caprylyl / capryl glucoside, laurylglucoside, cocoglucoside, caprylylglucoside, and mixtures thereof.

Cationic foaming surfactant

According to one embodiment, the composition according to the invention may comprise at least one cationic surfactant, in particular in the case where it comprises an amphoteric foaming surfactant. The cationic surfactants that can be used according to the present invention are in particular the salts of primary, secondary or tertiary fatty amines, optionally polyoxyalkylenated; quaternary ammonium salts; imidazoline derivatives; cationic amine oxides, and / or a mixture thereof.

• ceux qui présentent la formule générale (IV) suivante :
  
  dans laquelle les radicaux R₁ à R₄, qui peuvent être identiques ou différents, représentent un radical aliphatique, linéaire ou ramifié, comportant de 1 à 30 atomes de carbone, ou un radical aromatique tel que aryle ou alkylaryle. Les radicaux aliphatiques peuvent comporter des hétéroatomes tels que notamment l'oxygène, l'azote, le soufre, les halogènes. Les radicaux aliphatiques sont par exemple choisis parmi les radicaux alkyle, alcoxy, polyoxyalkylène(C₂-C₆), alkylamide, alkyl(C₁₂-C₂₂)amido alkyle(C₂-C₆), alkyl(C₁₂-C₂₂)acétate, hydroxyalkyle, comportant environ de 1 à 30 atomes de carbone; X est un anion choisi dans le groupe des halogénures, phosphates, acétates, lactates, alkyl(C₂-C₆)sulfates, alkyl-ou-alkylarylsulfonates, De préférence R₁ et R₂ désigne un alkyle en C₁-C₄, ou un hydroxyalkyle en C₁-C₄.
• les sels d'ammonium quaternaire de l'imidazolinium, comme par exemple celui de formule (V) suivante :
  
  dans laquelle R₅ représente un radical alcényle ou alkyle comportant de 8 à 30 atomes de carbone par exemple dérivés des acides gras de coprah, R₆ représente un atome d'hydrogène, un radical alkyle en C₁-C₄ ou un radical alcényle ou alkyle comportant de 8 à 30 atomes de carbone, R₇ représente un radical alkyle en C₁-C₄, R₈ représente un atome d'hydrogène, un radical alkyle en C₁-C₄, X^- est un anion choisi dans le groupe des halogénures, phosphates, acétates, lactates, alkylsulfates, alkyl-ou-alkylarylsulfonates. De préférence, R₅ et R₆ désignent un mélange de radicaux alcényle ou alkyle comportant de 12 à 21 atomes de carbone par exemple dérivés des acides gras du suif, R₇ désigne méthyle, R₈ désigne hydrogène.
• les sels de diammonium quaternaire de formule (VI) :
  
  dans laquelle R₉ désigne un radical aliphatique comportant environ de 16 à 30 atomes de carbone, R₁₀, R₁₁, R₁₂, R₁₃ et R₁₄, identiques ou différents sont choisis parmi l'hydrogène ou un radical alkyle comportant de 1 à 4 atomes de carbone, et X est un anion choisi dans le groupe des halogénures, acétates, phosphates, nitrates et méthyl-sulfates.
• les sels d'ammonium quaternaire contenant au moins une fonction ester par exemple ceux de formule (VII) suivante :
  
  dans laquelle :
  • R₁₅ est choisi parmi les radicaux alkyles en C₁-C₆ et les radicaux hydroxyalkyles ou dihydroxyalkyles en C₁-C₆ ;
  • R₁₆ est choisi parmi :
    • le radical
      
    • les radicaux R₂₀ hydrocarbonés en C₁-C₂₂ linéaires ou ramifiés, saturés ou insaturés,
    • l'atome d'hydrogène,
  • R₁₈ est choisi parmi :
    • le radical
      
    • les radicaux R₂₂ hydrocarbonés en C₁-C₆ linéaires ou ramifiés, saturés ou insaturés,
    • l'atome d'hydrogène,
  • R₁₇, R₁₉ et R₂₁, identiques ou différents, sont choisis parmi les radicaux hydrocarbonés en C₇-C₂₁, linéaires ou ramifiés, saturés ou insaturés ;
  • n, p et r, identiques ou différents, sont des entiers valant de 2 à 6 ;
  • y est un entier valant de 1 à 10 ;
  • x et z, identiques ou différents, sont des entiers valant de 0 à 10 ;
  • X^- est un anion simple ou complexe, organique ou inorganique ;

The quaternary ammonium salts are, for example:

• those who have the following general formula (IV):
  
  in which the radicals R ₁ to R ₄ , which may be identical or different, represent a linear or branched aliphatic radical containing from 1 to 30 carbon atoms, or an aromatic radical such as aryl or alkylaryl. Aliphatic radicals can include heteroatoms such as in particular oxygen, nitrogen, sulfur, halogens. The aliphatic radicals are for example chosen from alkyl, alkoxy, polyoxy (C ₂ -C ₆₎ alkylene, alkylamide, (C ₁₂ -C ₂₂₎ alkyl amido (C ₂ -C ₆₎ alkyl (C ₁₂ -C ₂₂ ) acetate, hydroxyalkyl, having from about 1 to 30 carbon atoms; X is an anion chosen from the group of halides, phosphates, acetates, lactates, (C ₂ -C ₆ ) alkyl sulphates, alkyl-or-alkylarylsulphonates, preferably R ₁ and R ₂ denotes a C ₁ -C ₄ alkyl, or a C ₁ -C ₄ hydroxyalkyl.
• the quaternary ammonium salts of imidazolinium, for example that of formula (V) below:
  
  in which R ₅ represents an alkenyl or alkyl radical containing from 8 to 30 carbon atoms, for example derived from coconut fatty acids, R ₆ represents a hydrogen atom, a C ₁ -C ₄ alkyl radical or an alkenyl radical or alkyl having from 8 to 30 carbon atoms, R ₇ represents a C ₁ -C ₄ alkyl radical, R ₈ represents a hydrogen atom, a C ₁ -C ₄ alkyl radical, X ^- is an anion chosen from group of halides, phosphates, acetates, lactates, alkylsulfates, alkyl-or-alkylarylsulfonates. Preferably, R ₅ and R ₆ denote a mixture of alkenyl or alkyl radicals containing from 12 to 21 carbon atoms, for example fatty acid derivatives of tallow, R ₇ denotes methyl, and R ₈ denotes hydrogen.
• the quaternary diammonium salts of formula (VI):
  
  in which R ₉ denotes an aliphatic radical containing about 16 to 30 carbon atoms, R ₁₀ , R ₁₁ , R ₁₂ , R ₁₃ and R ₁₄ , which may be identical or different, are chosen from hydrogen or an alkyl radical containing from 1 to 4 carbon atoms, and X is an anion selected from the group of halides, acetates, phosphates, nitrates and methyl sulfates.
• quaternary ammonium salts containing at least one ester function, for example those of formula (VII) below:
  
  in which :
  • R ₁₅ is selected from alkyl C ₁ -C ₆ hydroxyalkyl or dihydroxyalkyl radicals C ₁ -C ₆ alkyl;
  • R ₁₆ is chosen from:
    • The radical
      
    • R ₂₀ hydrocarbon radicals in C ₁ -C ₂₂ linear or branched, saturated or unsaturated,
    • the hydrogen atom,
  • R ₁₈ is selected from:
    • The radical
      
    • linear or branched, saturated or unsaturated C ₁ -C ₆ hydrocarbon radicals R ₂₂ ,
    • the hydrogen atom,
  • R ₁₇ , R ₁₉ and R ₂₁ , which are identical or different, are chosen from linear or branched, saturated or unsaturated C ₇ -C ₂₁ hydrocarbon radicals;
  • n, p and r, which may be identical or different, are integers ranging from 2 to 6;
  • y is an integer from 1 to 10;
  • x and z, which are identical or different, are integers ranging from 0 to 10;
  • X ^- is a simple or complex anion, organic or inorganic;

Provided that the sum x + y + z is from 1 to 15, that when x is 0, then R ₁₆ denotes R ₂₀ and that when z is 0, then R ₁₈ denotes R ₂₂ .

The alkyl radicals R ₁₅ may be linear or branched and more particularly linear.

Preferably R ₁₅ denotes a methyl, ethyl, hydroxyethyl or dihydroxypropyl radical and more particularly a methyl or ethyl radical.

Advantageously, the sum x + y + z is from 1 to 10.

When R ₁₆ is a radical R ₂₀ hydrocarbon, it may be long and contain from 12 to 22 carbon atoms or short and have from 1 to 3 carbon atoms.

When R ₁₈ is a hydrocarbon radical R ₂₂ , it preferably has 1 to 3 carbon atoms.

Advantageously, R ₁₇ , R ₁₉ and R ₂₁ , which are identical or different, are chosen from linear or branched, saturated or unsaturated C ₁₁ -C ₂₁ hydrocarbon radicals, and more particularly from C ₁₁ -C 15 alkyl and alkenyl radicals. ₂₁ , linear or branched, saturated or unsaturated.

Preferably, x and z, identical or different, are 0 or 1.

Advantageously, y is 1.

Preferably, n, p and r, identical or different, are 2 or 3 and even more particularly are equal to 2.

The anion is preferably a halide (chloride, bromide or iodide) or an alkyl sulphate more particularly methyl sulphate. However, it is possible to use methanesulphonate, phosphate, nitrate, tosylate, an anion derived from an organic acid such as acetate or lactate or any other anion compatible with ammonium with an ester function.

The anion X ^- is even more particularly chloride or methylsulfate.

• R₁₅ désigne un radical méthyle ou éthyle,
• x et y sont égaux à 1 ;
• z est égal à 0 ou 1 ;
• n, p et r sont égaux à 2 ;
• R₁₆ est choisi parmi :
  • le radical
    
  • les radicaux méthyle, éthyle ou hydrocarbonés en C₁₄-C₂₂
  • l'atome d'hydrogène ;
• R₁₈ est choisi parmi :
  • le radical
    
  • l'atome d'hydrogène ;

Ammonium salts of formula (VII) in which:

• R ₁₅ denotes a methyl or ethyl radical,
• x and y are equal to 1;
• z is 0 or 1;
• n, p and r are 2;
• R ₁₆ is chosen from:
  • The radical
    
  • methyl, ethyl or C ₁₄ -C ₂₂ hydrocarbon radicals
  • the hydrogen atom;
• R ₁₈ is selected from:
  • The radical
    
  • the hydrogen atom;

R ₁₇ , R ₁₉ and R ₂₁ , which are identical or different, are chosen from linear or branched, saturated or unsaturated C ₁₃ -C ₁₇ hydrocarbon radicals and preferably from linear C ₁₃ -C ₁₇ alkyl and alkenyl radicals or branched, saturated or unsaturated.

Advantageously, the hydrocarbon radicals are linear.

Of the quaternary ammonium salts of formula (IV), tetraalkylammonium chlorides, for example dialkyldimethylammonium or alkyltrimethylammonium chlorides, in which the alkyl radical contains approximately from 12 to 22 carbon atoms, are preferred. , in particular behenyltrimethylammonium, distearyldimethylammonium, cetyltrimethylammonium, benzyldimethylstearylammonium chlorides or, on the other hand, palmitylamidopropyltrimethylammonium chloride or stearamidopropyldimethyl (myristylacetate) ammonium chloride sold under the name "CERAPHYL 70" by the company VAN DYK.

There may be mentioned, for example, the compounds of formula (V) such as the salts (in particular chloride or methyl sulphate) of diacyloxyethyl dimethyl ammonium, of diacyloxyethyl hydroxyethyl methyl ammonium, of monoacyloxyethyl dihydroxyethyl methyl ammonium, of triacyloxyethyl methyl ammonium, of monoacyloxyethyl hydroxyethyl dimethyl ammonium and their mixtures. The acyl radicals preferably have from 14 to 18 carbon atoms. carbon and come more particularly from a vegetable oil such as palm oil or sunflower oil. When the compound contains more than one acyl radical, the latter may be identical or different.

These products are obtained for example by direct esterification of triethanolamine, triisopropanolamine, alkyldiethanolamine or alkyldiisopropanolamine optionally oxyalkylenated on fatty acids or mixtures of fatty acids of plant or animal origin or by transesterification of their esters methyl. This esterification is followed by a quaternization using an alkylating agent such as an alkyl halide (preferably methyl or ethyl), a dialkyl sulphate (methyl or preferably ethyl), methyl methanesulphonate, methyl paratoluenesulfonate, glycol or glycerol chlorohydrin.

Such compounds are for example sold under the names DEHYQUART by the company COGNIS, STEPANQUAT by the company STEPAN, NOXAMIUM by the company CECA, REWOQUAT WE 18 and REWOQUAT W75 by the company DEGUSSA.

It is also possible to use the ammonium salts containing at least one ester function described in the patents US Patent 4874554 and US Patent 4137180 .

Quaternary diammonium salts of formula (VI) that are suitable for the invention include, in particular, propane diammonium dichloride.

The amount (of active material) of additional foaming surfactant (s) in the composition according to the invention may range, for example, from 0.1 to 10% by weight, preferably from 0.2 to 7% by weight, and better from 0.5% to 5% by weight relative to the total weight of the composition.

The composition may comprise, besides the anionic and amphoteric surfactants and the additional surfactants, a polymeric quaternary ammonium salt (distinct from the previous surfactants) and / or a cationic galactomannan gum, preferably a cationic guar gum.

These compounds make it possible to increase the amount of foam and to obtain a sensation of softness of comfort on the skin (maintenance of hydration).

• ● Polyquaternium 5 tel que le produit MERQUAT 5 commercialisé par la société CALGON ;
• ● Polyquaternium 6 tel que le produit SALCARE SC 30 commercialisé par la société CIBA, et le produit MERQUAT 100 commercialisé par la société CALGON ;
• ● Polyquaternium 7 tel que les produits MEROUATS, MEROUAT 2200 et MEROUAT 550 commercialisés par la société CALGON, et le produit SALCARE SC 10 commercialisé par la société CIBA ;
• ● Polyquaternium 10 tel que le produit Polymer JR400 commercialisé par la société AMERCHOL;
• ● Polyquaternium 11 tel que les produits GAFQUAT 755, GAFQUAT 755N et GAFOUAT 734 commercialisés par la société ISP ;
• ● Polyquaternium 15 tel que le produit ROHAGIT KF 720 F commercialisé par la société ROHM ;
• ● Polyquaternium 16 tel que les produits LUVIQUAT FC905, LUVIQUAT FC370, LUVIQUAT HM552 et LUVIQUAT FC550 commercialisés par la société BASF ;
• ● Polyquaternium 22 tel que le produit MEROUAT 280 commercialisé par la société CALGON ;
• ● Polyquaternium 28 tel que le produit STYLEZE CC10 commercialisé par la société ISP ;
• ● Polyquaternium 39 tel que le produit MERQUAT PLUS 3330 commercialisé par la société CALGON ;
• ● Polyquaternium 44 tel que le produit LUVIQUAT CARE commercialisé par la société BASF;
• ● Polyquaternium 46 tel que le produit LUVIQUAT HOLD commercialisé par la société BASF;
• ● Polyquaternium 47 tel que le produit MERQUAT 2001 commercialisé par la société CALGON.

The polymeric quaternary ammonium salts are cationic or amphoteric polymers containing at least one quaternized nitrogen atom. As salts polymeric quaternary ammonium, there may be mentioned Polyquaternium (CTFA name), which provide softness and creaminess to the foaming cream. These polymers may be chosen preferably from the following polymers:

• ● Polyquaternium 5 such as the MERQUAT 5 product marketed by Calgon;
• ● Polyquaternium 6 such as the SALCARE SC 30 product marketed by the company CIBA, and the MERQUAT 100 product marketed by the company CALGON;
• ● Polyquaternium 7 such as MEROUATS products MEROUAT 2200 and MEROUAT 550 marketed by the company CALGON, and the SALCARE SC 10 product marketed by the company CIBA;
• ● Polyquaternium 10 such as the product Polymer JR400 marketed by the company Amerchol;
• ● Polyquaternium 11 such as GAFQUAT 755, GAFQUAT 755N and GAFOUAT 734 products marketed by ISP;
• ● Polyquaternium 15 such as the product ROHAGIT KF 720 F marketed by the company ROHM;
• ● Polyquaternium 16 such as LUVIQUAT products FC905, LUVIQUAT FC370, LUVIQUAT HM552 and LUVIQUAT FC550 marketed by BASF;
• ● Polyquaternium 22 such as the MEROUAT 280 product marketed by Calgon;
• Polyquaternium 28 such as the product STYLEZE CC10 marketed by the company ISP;
• ● Polyquaternium 39 such as the MERQUAT PLUS 3330 product marketed by Calgon;
• ● Polyquaternium 44 such as the LUVIQUAT CARE product marketed by BASF;
• ● Polyquaternium 46 such as the product LUVIQUAT HOLD marketed by BASF;
• ● Polyquaternium 47 such as the product MERQUAT 2001 marketed by Calgon.

Preferably, the quaternary ammonium salts are chosen from Polyquaternium-7, Polyquaternium-10, Polyquaternium-39, Polyquaternium-47, and mixtures thereof.

The cationic galactomannan gums preferably have a cationic charge density less than or equal to 1.5 meq / g and more particularly between 0.1 and 1 meq / g.
In general terms, within the meaning of the present invention, the term "cationic galactomannan gum" means any galactomannan gum containing cationic groups and / or ionizable groups in cationic groups.
Preferred cationic groups are chosen from those comprising primary, secondary, tertiary and / or quaternary amine groups.
The cationic galactomannan gums used generally have a weight average molecular weight of between about 500 and 5 × 10 6, and preferably between about 103 and 3 × 10 6.
The cationic galactomannan gums that can be used according to the present invention are, for example, gums comprising cationic trialkyl (C 1 -C 4) ammonium groups. Preferably, 2 to 30% by number of the hydroxyl functions of these gums carry trialkylammonium cationic groups.
Among these trialkylammonium groups, there may be mentioned very particularly trimethylammonium and triethylammonium groups.
Even more preferentially, these groups represent from 5 to 20% by weight of the total weight of the modified galactomannan gum.
According to the invention, a guar gum comprising hydroxypropyltrimethylammonium groups, that is to say a guar gum modified for example with 2,3-epoxypropyltrimethylammonium chloride, is preferably used.
These galactomannan gums, in particular guar gums modified with cationic groups, are products that are already known per se and are for example described in the patents. US 3,589,578 and US 4,031,307 . Such products are also sold in particular under the trade names JAGUAR C13S, JAGUAR C15, JAGUAR C17 and JAGUAR C162 by MEYHALL.

The polymeric quaternary ammonium salts and / or the cationic galactomannan gums may be in an amount (of active material) ranging, for example, from 0.01 to 5% by weight and better still from 0.05 to 1% by weight relative to to the total weight of the composition.

According to one embodiment, the composition according to the invention comprises an aqueous phase containing water and optionally one or more water-soluble organic solvents. In this aqueous medium, the amount of water is preferably at least 20% by weight; it is preferably from 20 to 95% by weight, better still from 30 to 90% by weight and still more preferably from 40 to 85% by weight relative to the total weight of the composition.

The water-soluble solvents may be chosen from the lower water-soluble alcohol (s). By lower alcohol is meant an alcohol having 1 to 8 carbon atoms. Lower alcohols include, for example, ethanol, isopropanol, butanol and mixtures thereof. When present in the composition of the invention, the water-soluble lower alcohol (s) may be in an amount ranging from 0.01 to 40% by weight.

The aqueous phase may also comprise polyols (or polyhydric alcohols) such as, for example, glycerine; glycols such as propylene glycol, butylene glycol, isoprene glycol and polyethylene glycols such as PEG-8; sorbitol; sugars such as glucose, fructose, maltose, lactose, sucrose; and their mixtures. The amount of polyols is generally from 0.1 to 60% by weight and better still from 0.5 to 50% by weight relative to the total weight of the aqueous phase.

According to one embodiment, the composition according to the invention comprises less than 5% by weight of water, preferably less than 3% and better still less than 2%, it can be totally free of water (anhydrous composition). It may however comprise water-soluble solvents such as the lower alcohols or the polyols mentioned above.

Oils

• les huiles essentielles
• les huiles hydrocarbonées d'origine animale, telles que le perhydrosqualène ;
• les huiles hydrocarbonées d'origine végétale, telles que les triglycérides liquides d'acides gras comportant de 4 à 30 atomes de carbone comme les triglycérides des acides heptanoïque ou octanoïque ou encore, par exemple, les huiles de tournesol, de jojoba, de maïs, de soja, de courge, de pépins de raisin, de sésame, de noisette, d'abricot, de macadamia, d'arara, de coriandre, de ricin, d'avocat, les triglycérides des acides caprylique/caprique comme ceux commercialisés par la société Stearineries Dubois ou ceux commercialisés sous les dénominations Miglyol 810, 812 et 818 par la société Dynamit Nobel, l'huile de beurre de karité;

• les esters et les éthers de synthèse, notamment d'acides gras, comme les huiles de formules R¹COOR² et R¹OR² dans laquelle R¹ représente le reste d'un acide gras ou d'un alcool gras comportant de 8 à 29 atomes de carbone, et R² représente une chaîne hydrocarbonée, ramifiée ou non, contenant de 3 à 30 atomes de carbone, comme par exemple l'huile de Purcellin, le stéarate d'octyl-2-dodécyle, l'érucate d'octyl-2-dodécyle, l'isostéarate d'isostéaryle ; les esters hydroxylés comme l'isostéaryl lactate, l'octylhydroxystéarate, l'hydroxystéarate d'octyldodécyle, le diisostéaryl-malate, le citrate de triisocétyle, les heptanoates, octanoates, décanoates d'alcools gras ; les esters de polyol, comme le dioctanoate de propylène glycol, le diheptanoate de néopentylglycol et le diisononanoate de diéthylèneglycol ; et les esters du pentaérythritol comme le tétraisostéarate de pentaérythrytyle ;
• les hydrocarbures linéaires ou ramifiés, d'origine minérale ou synthétique, tels que les huiles de paraffine, volatiles ou non, et leurs dérivés, la vaseline, les polydécènes, l'isohexadecane, l'isododecane, le polyisobutène hydrogéné tel que l'huile de Parléam® ;
• les huiles de silicone comme les polyméthylsiloxanes (PDMS) volatiles ou non à chaîne siliconée linéaire ou cyclique, liquides ou pâteux à température ambiante, notamment les huiles de silicone volatiles, en particulier cyclopolydiméthylsiloxanes (cyclométhicones) telles que le cyclohexadiméthylsiloxane et le cyclopentadiméthylsiloxane ; les polydiméthyl-siloxanes comportant des groupements alkyle, alcoxy ou phényle, pendant ou en bout de chaîne siliconée, groupements ayant de 2 à 24 atomes de carbone ; les silicones phénylées comme les phényltriméthicones, les phényldiméthicones, les phényltriméthylsiloxydiphényl-siloxanes, les diphényl-diméthicones, les diphénylméthyldiphényl trisiloxanes, les 2-phényléthyltriméthyl-siloxysilicates, et les polyméthylphénylsiloxanes ;
• leurs mélanges.

The composition according to the invention may comprise an oil. As oils that can be used in the composition of the invention, mention may be made for example of:

• essential oils
• hydrocarbon oils of animal origin, such as perhydrosqualene;
• hydrocarbon-based oils of vegetable origin, such as liquid triglycerides of fatty acids containing from 4 to 30 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, jojoba and corn oils, soya, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, coriander, castor oil, avocado, triglycerides caprylic / capric acids such as those marketed by Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel, shea butter oil;

• esters and synthetic ethers, especially of fatty acids, such as the oils of formulas R ¹ COOR ² and R ¹ OR ² in which R ¹ represents the residue of a fatty acid or of a fatty alcohol containing from 8 to 29 carbon atoms, and R ² represents a hydrocarbon chain, branched or unbranched, containing from 3 to 30 carbon atoms, such as for example purcellin oil, octyl-2-dodecyl stearate, erucate octyl-2-dodecyl, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, heptanoates, octanoates, decanoates of fatty alcohols; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters such as pentaerythritol tetraisostearate;
• linear or branched hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, isohexadecane, isododecane, hydrogenated polyisobutene such as oil Parleam®;
• silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular volatile silicone oils, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexadimethylsiloxane and cyclopentadimethylsiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl-dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes;
• their mixtures.

The oil may be present in a content ranging from 0.5% to 15% by weight relative to the total weight of the composition, preferably less than or equal to 1% to 12% by weight.

The compositions of the invention may also contain adjuvants usually used in the cosmetics field. As adjuvants, there may be mentioned for example perfumes, preservatives, sequestering agents (EDTA), pigments, especially exfoliating fillers, soluble dyes, sunscreens, cosmetic or dermatological active agents such as moisturizers such as hyaluronic acid. ; ceramides ; water-soluble or fat-soluble vitamins such as vitamin C and its derivatives such as vitamin CG; antiseptics; antiseborrhoeic; antimicrobials such as benzoyl peroxide, salicylic acid, triclosan, azelaic acid; optical brighteners. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01 to 5% of the total weight of the composition. These adjuvants and their concentrations must be such that they do not modify the desired property for the composition of the invention.

Examples of exfoliating agents are exfoliating or exfoliating particles of mineral, plant or organic origin. Thus, for example, beads or polyethylene powder, nylon powder, polyvinyl chloride powder, pumice, ground apricot kernels or nut shells can be used. sawdust, glass beads, alumina, and mixtures thereof. These particles may be present in an amount ranging for example from 0.5 to 40% by weight, preferably from 1 to 20% by weight and better still from 1 to 10% by weight relative to the total weight of the composition. When the composition contains exfoliating particles, it may constitute in particular a composition for scrubbing the skin of the face or body.

The compositions of the invention may also contain polymers, in particular anionic and nonionic polymers.

As anionic polymers, there may be mentioned in particular those comprising at least one hydrophobic chain, and in particular those derived from acrylic or methacrylic acid, such as the acrylate / steareth-20 methacrylate copolymer sold under the name Aculyn 22 by the company Rohm & Haas ( CTFA name: Acrylates / Steareth-30 Methacrylate Copolymer); the (meth) acrylic acid / ethyl acrylate / oxyethylenated behenyl methacrylate terpolymer (25 EO), in aqueous emulsion marketed under the name Aculyn 28 by the company Rohm &Haas; the acrylic acid / itaconate copolymer of oxyethylenated mono-cetyl (20 EO), in a 30% aqueous dispersion sold under the name Structure 3001 by the company National Starch; the acrylic acid / itaconate copolymer of oxyethylenated mono-stearyl (20 EO) in 30% aqueous dispersion sold under the name Structure 2001 by the company National Starch; the acrylate / acrylate copolymer modified with C 12 -C 24 polyoxyethylenated alcohols (25 EO), in the form of a 30-32% latex of copolymer, sold under the name Synthalen W2000 by the company 3V SA, as well as the copolymers sold under the names PEMULEN or CARBOPOL by the Noveon Company, such as the acrylate / C ₁₀ -C ₃₀ -alkyl acrylate copolymer, such as the PEMULEN TR1 or CARBOPOL 1382 products (CTFA name: Acrylates / C10-30 Alkyl Acrylate Crosspolymer).

• l'homopolymère réticulé et neutralisé d'acide 2-acrylamido 2-méthylpropane sulfonique, commercialisé par la société Clariant sous la dénomination commerciale « Hostacerin AMPS » (nom CTFA : ammonium polyacryldimethyltauramide) ;
• les copolymères anioniques réticulés d'acrylamide ou méthylacrylamide et d'acide 2-acrylamido-2-méthylpropane sulfonique, notamment ceux se présentant sous la forme d'une émulsion E/H, tels que ceux commercialisés sous le nom de SEPIGEL 305 par la société Seppic (nom C.T.F.A. : Polyacrylamide / C13-14 Isoparaffin / Laureth-7), sous le nom de SIMULGEL 600 par la société Seppic (nom C.T.F.A. : Acrylamide / Sodium acryloyldimethyltaurate copolymer / Isohexadecane / Polysorbate 80),
• les copolymères d'acide(méth)acrylique ou de (méth)acrylate et d'acide 2-acrylamido-2-méthylpropane sulfonique, notamment ceux se présentant sous la forme d'une émulsion E/H, tels que ceux commercialisés sous le nom de SIMULGEL NS par la société Seppic (copolymère d'acrylamido-2-methyl propane sulfonate de sodium / hydroxyethyl acrylate en émulsion inverse à 40% dans Polysorbate 60 et squalane) (nom CTFA : hydroxyethyl acrylate/sodium acryloyldimethyltaurate copolymer / squalane / polysorbate 60) ou ceux commercialisés sous le nom de SIMULGEL EG par la société Seppic (copolymère d'acide acrylique / acrylamido-2-methylpropane-sulfonique sous forme de sel de sodium en émulsion inverse à 45% dans isohexadecane / eau) (nom C.T.F.A. : Sodium Acrylate / Sodium acryloydimethyl-taurate copolymer Isohexadecane / Polysorbate 80),
• les copolymères d'acide 2-acrylamido-2-méthylpropane sulfonique et de vinylpyrrolidone ou de vinylformamide, tels que les produits commercialisés sous les dénominations ARISTOFLEX AVC par la société Clariant,
• les polymères d'AMPS modifiés hydrophobes comme notamment le copolymère d'AMPS et de methacrylate d'alcool en C12-C14 éthoxylé (copolymère non réticulé obtenu à partir de Genapol LA-070 et d'AMPS) (nom CTFA: Ammonium Acryloyldimethyltaurate / Laureth-7 Methacrylate Copolymer) commercialisé sous la dénomination ARISTOFLEX LNC par la société Clariant, et le copolymère d'AMPS et de méthacrylate de stéaryle éthoxylé (25 EO) (copolymère réticulé par le trimethylolpropane triacrylate, obtenu à partir de Genapol T-250 et d'AMPS) (nom CTFA : Ammonium Acryloyldimethyltaurate / Steareth-25 Methacrylate Crosspolymer) commercialisé sous la dénomination ARISTOFLEX HMS par la société Clariant.

The composition may also contain polymers comprising at least one monomer containing a sulfonic group, and in particular 2-acrylamido-2-methylpropanesulphonic acid (AMPS) polymers and copolymers, such as:

• the crosslinked and neutralized homopolymer of 2-acrylamido-2-methylpropanesulphonic acid, marketed by the company Clariant under the trademark "Hostacerin AMPS" (CTFA name: ammonium polyacryldimethyltauramide);
• crosslinked anionic copolymers of acrylamide or methylacrylamide and of 2-acrylamido-2-methylpropanesulphonic acid, in particular those in the form of an W / O emulsion, such as those marketed under the name SEPIGEL 305 by the company Seppic (CTFA name: Polyacrylamide / C13-14 Isoparaffin / Laureth-7), under the name SIMULGEL 600 by the company Seppic (CTFA name: Acrylamide / Sodium acryloyldimethyltaurate copolymer / Isohexadecane / Polysorbate 80),
• copolymers of (meth) acrylic acid or (meth) acrylate and 2-acrylamido-2-methylpropanesulphonic acid, in particular those in the form of an W / O emulsion, such as those marketed under the name of SIMULGEL NS by the company Seppic (copolymer of acrylamido-2-methyl propane sulfonate sodium / hydroxyethyl acrylate in 40% inverse emulsion in Polysorbate 60 and squalane) (CTFA name: hydroxyethyl acrylate / sodium acryloyldimethyltaurate copolymer / squalane / polysorbate 60 or those marketed under the name SIMULGEL EG by the company Seppic (acrylic acid / acrylamido-2-methylpropanesulphonic copolymer in the form of 45% inverse sodium salt in isohexadecane / water) (CTFA name: Sodium Acrylate / Sodium acryloylmethyl-taurate copolymer Isohexadecane / Polysorbate 80),
• copolymers of 2-acrylamido-2-methylpropanesulphonic acid and of vinylpyrrolidone or of vinylformamide, such as the products sold under the names ARISTOFLEX AVC by the company Clariant,
• hydrophobically modified AMPS polymers such as, in particular, the copolymer of AMPS and of ethoxylated C12-C14 alcohol methacrylate (non-crosslinked copolymer obtained from Genapol LA-070 and AMPS) (CTFA name: Ammonium Acryloyldimethyltaurate / Laureth -7 Methacrylate Copolymer) sold under the name ARISTOFLEX LNC by the company Clariant, and the copolymer of AMPS and of ethoxylated stearyl methacrylate (25 EO) (copolymer crosslinked with trimethylolpropane triacrylate, obtained from Genapol T-250 and AMPS) (CTFA name: Ammonium Acryloyldimethyltaurate / Steareth-25 Methacrylate Crosspolymer) sold under the name ARISTOFLEX HMS by Clariant society.

These polymers may be in an amount (of active material) ranging for example from 0.05 to 10% by weight and better still from 0.1 to 5% by weight relative to the total weight of the composition.

The compositions according to the invention can be used on all keratin materials such as the skin, the scalp, the hair, the eyelashes, the eyebrows, the nails or the mucous membranes, especially as a hygiene product, for example as a product of the invention. cleaning the skin, the mucous membranes and / or the hair, in particular as a cleansing and / or cleansing product for the skin (face and / or body), as a shower product (two-in-one product), as a shampoo and conditioner, as a shaving product, as a mask for rinsing, and as an exfoliating product (also called desquamating or descaling) for the face, the body or the hands, after the addition of exfoliating particles.

The subject of the invention is also the cosmetic use of the composition as defined above, as a product for cleaning and / or removing make-up from the skin, as a shower product, as a shampoo, as a conditioner product, as a product as a rinsing mask, as an exfoliating product.

Another subject of the invention is a method for cleaning a keratin material, such as the skin, the scalp, the hair, the eyelashes, the eyebrows, the nails or the mucous membranes, characterized in that it applies on the keratin material, a composition as defined above, and rinsed.

The keratinous material is preferably the skin.

1. 1) quand les compositions selon l'invention constituent des produits de nettoyage doux pour le visage, elles peuvent être utilisées de la manière suivante :
   • on fait mousser le produit dans les mains avec de l'eau
   • on applique la mousse sur le visage
   • on nettoie le visage
   • on rince à l'eau
2. 2) quand les compositions selon l'invention constituent des produits démaquillants, elles peuvent être utilisées comme indiqué ci-dessus mais elles peuvent aussi être appliquées à sec sur le visage, puis massées jusqu'à obtention d'un démaquillage satisfaisant, et rincées à l'eau, ou bien elles peuvent être appliquées au moyen d'un coton.
3. 3) on peut les utiliser comme produit de douche deux-en-un, comme shampooing et/ou après shampooing, comme masque à rincer ou comme produit de rasage, de la manière habituelle d'utilisation de ces produits.

The compositions according to the invention can for example be used in the following manner:

1. 1) when the compositions according to the invention constitute mild cleaning products for the face, they can be used as follows:
   • the product is lathered in the hands with water
   • we apply the mousse on the face
   • we clean the face
   • we rinse with water
2. 2) when the compositions according to the invention are makeup removers, they can be used as indicated above but they can also be applied dry on the face, then massaged until a satisfactory makeup removal, and rinsed to water, or they can be applied by means of a cotton.
3. 3) they can be used as a two-in-one shower product, as a shampoo and / or after shampoo, as a mask to rinse or as a shaving product, in the usual manner of using these products.

The examples which follow serve to illustrate the invention without, however, being limiting in nature. The amounts indicated are in% by weight unless otherwise indicated, and they correspond unless otherwise stated to the amount of raw material and not to the amount of active ingredient. The names of the compounds used are indicated in CTFA name, chemical name or trade name.

Examples

• Avant toute utilisation du produit, les mains sont lavées au savon de Marseille puis convenablement rincées et séchées. Puis le protocole suivi est le suivant :
  1. 1- mouiller les mains en les passant sous l'eau courante, les secouer trois fois pour les enlever l'excès d'eau,
  2. 2- placer 1 g de produit dans le creux de l'une des mains,
  3. 3- travailler le produit entre les deux paumes pendant 10 secondes,
  4. 4- ajouter 2 ml d'eau et travailler le produit à nouveau pendant 10 secondes,
  5. 5- rincer les mains sous l'eau ,
  6. 6- les essuyer.

In the examples which follow, the foam performances (foam qualities) are evaluated according to the following protocol:

• Before any use of the product, the hands are washed with Marseille soap then properly rinsed and dried. Then the protocol followed is as follows:
  1. 1- wet hands under running water, shake them three times to remove excess water,
  2. 2- place 1 g of product in the hollow of one of the hands,
  3. 3- work the product between the two palms for 10 seconds,
  4. 4- add 2 ml of water and work the product again for 10 seconds,
  5. 5- rinse hands under water,
  6. 6- wipe them.

• volume de mousse : la note attribuée est d'autant plus élevée que le volume est grand.
• taille des bulles composant la mousse : la note attribuée est d'autant plus élevée que les bulles sont grosses.
• densité : consistance, tenue de la mousse ; la note attribuée est d'autant plus élevée que la densité est grande.

The following criteria are evaluated:

• Foam volume: The higher the volume, the higher the rating.
• size of the bubbles composing the foam: the score awarded is even higher than the bubbles are large.
• density: consistency, holding of the foam; the score awarded is even higher than the density is large.

They are noted on a scale of 0 to 10. It is considered that, for a given criterion, there is a difference of note between two products when the difference between 2 notes is greater than or equal to 0.5.

The evaluation panel consists of 3 trained experts. The average of the 3 notes makes it possible to compare the compositions according to each of the criteria.

Examples 1 to 3

The following compositions are prepared: Example 1 (invention) Example 1 '(comparative) Example 2 (invention) Example 2 (Comparative) Example 3 (Invention) Example 3 '(comparative) Lauryl Ether Sulfate (70% MA) (1) 18.6% 18.6% - - - - Laureth-5 carboxylic acid (90% - - 14.44% 14.44% - - MA) (2) Cocobetaine (30% MA) (3) - - - - 43.33% 43.33% Sodium salt of 3- acid 6.67% - 6.67% - 6.67% - hydroxy-2-pentyl-cyclopentane 30% acetic acid in a mixture water / dipropylene glycol (70/30). Water 74.73% 81.4% 69.75% 75.56% 50% 56.67% 10% soda in water - - 9.14% 10% - - Aspect Transparent clear solution Transparent clear solution Transparent clear solution Transparent clear solution Transparent clear solution Transparent clear solution pH 7.2 8 6.7 6.8 6.9 7.5 Notes: Before adding water: Volume of foam 3.2 2.7 3.5 2.2 4.5 3.5 Bubble size 3.8 3.7 3.8 2.3 6.5 6.3 Density of the foam 7.5 6.2 7 5.3 7.3 6.8 After adding water: Volume of foam 6.7 5.7 6.3 4.7 7.7 6.5 Bubble size 5 5.5 4 4.2 6.7 6.3 Density of the foam 6.8 5.3 6.7 5.5 9.7 9 (1) TEXAPON AOS 225 UP (COGNIS)
(2) AKYPO RLM 45 CA (KAO)
(3) GENAGEN KB (CLARIANT)

Procedure: the mixtures of surfactants are made at ambient temperature at the magnetic bar. The 3-hydroxy-2-pentylcyclopentane acetic acid salt, if present, is added cold to the surfactant solution.

These examples show that addition of the jasmonic acid derivative increases the volume and density of identical bubble-size foam in anionic or amphoteric surfactant bases.

Examples 4 and 4 'Foaming Cleansing Creams

Phase Example 4 (Invention) Example 4 (Comparative) Water A1 8.42% 8.42% Carbomer (1) A2 0.25% 0.25% Glycerin A3 39.3% 39.3% Guar hydroxypropyl trimonium chloride (30% MA) (2) A4 0.25% 0.25% Sodium cocoyl glycinate (52% MA) (3) B1 43.33% 43.33% Glycol distearate B2 1.8% 1.8% Stearic acid B3 1.1% 1.1% Polyquaternium-39 (10% MA) (4) VS 2.5% 2.5% Citric acid (20%) D 2.55% 2.55% Perfume E 0.5% 0.5% Sodium salt of 3-hydroxy-2-pentyl-cyclopentane acetic acid at 30% in a water / dipropylene glycol mixture (70/30). F 6.67% - Aspect White cream White cream pH 7.0 7.0 Sensory notes Before adding water: Volume of foam 5.3 6.5 Bubble size 2.3 2.5 Density of the foam 7 8 After adding water: Volume of foam 7.5 8.5 Bubble size 2.5 2.5 Density of the foam 7.5 8 (1) CARBOPOL ULTREZ 10 (LUBRIZOL)
(2) JAGUAR C 162 (RHODIA)
(3) AMILITE GCS-12K (AJINOMOTO)
(4) MERQUAT PLUS 3330 (NALCO)

Operating mode:

1. 1- Prepare phase A = A1 + A2 + A3 + A4 under deflocculator at room temperature.
2. 2- Heat the phase B = B1 + B2 + B3 at 70-75 ° C in the water bath.
3. 3- Gradually introduce the aqueous phase A into the hot fatty phase B, homogenize for 10 min at 50-55 ° C
4. 4- Incorporate C, D, E and F
5. 5- Cool under deflocculator

These examples show that the presence of the 3-hydroxy-2-pentylcyclopentane acetic acid salt significantly improves the foam quality of a composition comprising a surfactant composition comprising an anionic surfactant.
The composition of Example 4 according to the invention gives an abundant and dense foam, it rinses well and is well tolerated by the skin. It can be advantageously used for cleaning the skin of the face.

Examples 5 and 5 ': Foaming liquid soap creams

Example 5 Example 5 Sodium Lauryl Ether Sulfate (70% MA) (1) 30.33% 30.33% Alkyl Polyglucoside (52% MA) (2) 7.5% 7.5% Water 62.17% 55.5% Sodium salt of 3-hydroxy-2-pentyl-cyclopentane acetic acid at 30% in a water / dipropylene glycol mixture (70/30). 6.67% Citric acid (10% MA) Qsp pH Qsp pH Aspect Transparent solution Transparent solution pH 7.1 7.2 Sensory notes Before adding water: Volume of foam 4.5 7 Bubble size 5.3 4.3 Density of the foam 5.5 7.3 After adding water: Volume of foam 6 9.5 Bubble size 6.5 5 Density of the foam 2.5 7 (1) TEXAPON AOS 225 UP (COGNIS)
(2) PLANTACARE 818 UP (COGNIS)

The presence of 3-hydroxy-2-pentylcyclopentane acetic acid salt significantly improves the foam quality of the composition according to the invention.

Claims (15)

A cleaning composition comprising (1) at least one anionic or amphoteric foaming surfactant and (2) at least one jasmonic acid derivative compound selected from those of formula (I) below:

in which : - R1 represents a radical COOR3, R3 denoting a hydrogen atom or a C1-C4 alkyl radical, optionally substituted by one or more hydroxyl groups; R2 represents a hydrocarbon radical, saturated or unsaturated, linear having 1 to 18 carbon atoms, or branched or cyclic having 3 to 18 carbon atoms; as well as their optical isomers, and corresponding salts. Composition according to Claim 1, characterized in that , in the compound of formula (I), R ₁ denotes a radical chosen from -COOH, -COOMe, -COO-, CH 2 -CH 3, -COO-CH 2 -CH (OH) -CH2OH, -COOCH2-CH2-CH2OH, -COOCH2-CH (OH) -CH3. Composition according to Claim 1 or 2, characterized in that , in the compound of formula (I), R1 denotes a -COOH radical. Composition according to any one of the preceding claims, characterized in that , in the compound of formula (I), R ₂ denotes a hydrocarbon radical, linear, saturated or unsaturated, and preferably having from 2 to 7 carbon atoms. Composition according to any one of the preceding claims, characterized in that R2 is a pentyl, pentenyl, hexyl or heptyl radical. Composition according to any one of the preceding claims, characterized in that the compound of formula (I) is chosen from 3-hydroxy-2 - [(2Z) -2-pentenyl] -cyclopentane acetic acid or acid 3 2-pentylcyclopentane acetic acid. Composition according to any one of the preceding claims, characterized in that the salts of the compounds of formula (I) are chosen from the alkali metal salts, the alkaline earth metal salts, the metal salts, the ammonium salts of NH ₄ ⁺ formula; quaternary ammonium salts; organic amine salts, lysine salts, arginine salts. Composition according to any one of the preceding claims, characterized in that the compound of formula (I) is present in an amount ranging from 0.1 to 15% by weight, preferably from 0.2 to 10% by weight and better from 0.5 to 10% by weight relative to the total weight of the composition. Composition according to any one of the preceding claims, characterized in that the anionic and / or amphoteric foaming surfactants are present in an amount (of active material) ranging from 0.1 to 40% by weight, preferably from 0.5 to 30% by weight, better from 1 to 25% and even better from 3 to 20% by weight relative to the total weight of the composition. Composition according to any one of the preceding claims, characterized in that the anionic surfactant is chosen from anionic derivatives of proteins of plant origin or silk proteins, phosphates and alkylphosphates, carboxylates, sulphosuccinates and amino acid derivatives. alkyl sulphates, alkyl ether sulphates, sulphonates, isethionates, taurates, alkyl sulphoacetates, polypeptides, anionic alkyl polyglucoside derivatives, soaps (fatty acid salts) and mixtures thereof. Composition according to any one of the preceding claims, characterized in that the anionic surfactant is chosen from amino acid derivatives, alkyl sulphates, alkyl ether sulphates, isethionates, amino acid derivatives and their mixtures. Composition according to the preceding claim, characterized in that the amphoteric or zwitterionic surfactant is chosen from betaines, N-alkylamidobetaines and their derivatives, sultaines, alkyl polyaminocarboxylates, alkylamphoacetates and mixtures thereof. Composition according to the preceding claim, characterized in that the amphoteric or zwitterionic surfactant is chosen from betaines, and in particular alkylbetaines, alkylamphoacetates and mixtures thereof. Composition according to any one of the preceding claims, characterized in that it further comprises at least one polymeric quaternary ammonium salt (distinct from the preceding surfactants) and / or at least one cationic galactomannan gum, preferably a gum of cationic guar. Process for cleaning a keratinous material, characterized in that a composition according to any one of Claims 1 to 14 is applied to the keratinous material and rinsed.